HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 345147Generated: October 29, 2026
Ethyl bromoacetate → HCID 14648629, compound
https://huagongshe.com/reaction/345147
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Ethyl bromoacetate | HCID 7748 | — |
| Reactant | Sodium hydride | HCID 24758 | — |
| Reactant | HCID 14648628 | HCID 14648628 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | HCID 14648629 | HCID 14648629 | — |
Reaction Steps
In the same manner as in (iv) of Example 1, 1.5 g of 2-p-methoxyphenyl-3-(2-naphthalenecarboxamido)-2,3-dihydro-1,5-benzothiazepin-4(5H)-one is dissolved in 30 ml of dimethylformamide, whereto 0.145 g of 60% sodium hydride is added under ice-cooling. After the mixture is stirred at room temperature for 30 minutes, 5 ml of dimethylformamide containing 0.45 ml of ethyl bromoacetate is added dropwise. The mixture is stirred at room temperature for 3 hours, and then the reaction mixture is concentrated under reduced pressure. Chloroform and water are added to the residue to separate the organic layer. The chloroform layer is washed with water and dried. The solvent is distilled off under reduced pressure. A mixed solvent of isopropyl alcohol-isopropyl ether is added thereto. The resulting crystals are collected by filtration to give 1.8 g of ethyl 2-p-methoxyphenyl-3-(2-naphthalenecarboxamido)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepine-5acetate, m.p. 183°-186° C.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US05055464 |
|---|
| Source dataset | uspto-grants-1991_10 |
|---|
| ORD ID | ord-1cd8886fac05485ab306fa8d8c62fb12 |
|---|
| Source note | uspto-grants-1991_10 |
|---|